Alexion Pharma (ALXN) Tops Q3 EPS by 28c, Revenues Beat; Boosts FY18 EPS/Revenue/Operating Margin Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. MU

Go back to Alexion Pharma (ALXN) Tops Q3 EPS by 28c, Revenues Beat; Boosts FY18 EPS/Revenue/Operating Margin Outlook

Alexion Pharmaceuticals, Inc. (ALXN), Dicerna Pharma (DRNA) Report Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases

October 24, 2018 6:42 AM EDT

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) today announced... More